Newbridge Financial Services Group’s Precision BioSciences DTIL Stock Holding History

Newbridge Financial Services Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6K	Hold	1,600	–	–	﹤0.01%	815
2026 Q1	$8.8K	Hold	1,600	–	–	﹤0.01%	817
2025 Q4	$6.66K	Hold	1,600	–	–	﹤0.01%	854
2025 Q3	$8.83K	Hold	1,600	–	–	﹤0.01%	923
2025 Q2	$6.72K	Hold	1,600	–	–	﹤0.01%	976
2025 Q1	$7.63K	Hold	1,600	–	–	﹤0.01%	729
2024 Q4	$6.1K	Buy	+1,600	New	+$11.7K	﹤0.01%	834
2021 Q4	–	Sell	-915	Closed	-$256K	–	1441
2021 Q3	$317K	Sell	915 -25	-3%	-$8.47K	0.2%	115
2021 Q2	$353K	Sell	940 -395	-30%	-$119K	0.22%	108
2021 Q1	$415K	Buy	1,335 +1,310	+5,240%	+$459K	0.31%	76
2020 Q4	$6K	Buy	+25	New	+$6.13K	﹤0.01%	813

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Newbridge Financial Services Group's DTIL Position: Q2 2026 in Review

Newbridge Financial Services Group held its Precision BioSciences (DTIL) position steady in Q2 2026 at 1,600 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Newbridge Financial Services Group first reported a position in DTIL in Q4 2020 and has held it in 11 quarters since. The position peaked at $415K in Q1 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

Newbridge Financial Services Group held 1,600 shares of Precision BioSciences worth $12.6K as of Q2 2026.
Newbridge Financial Services Group left its Precision BioSciences share count unchanged in Q2 2026.
Precision BioSciences made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #815 holding.
Newbridge Financial Services Group first reported a position in Precision BioSciences in Q4 2020 and has held it in 11 quarters since.
Newbridge Financial Services Group's Precision BioSciences position peaked at $415K in Q1 2021.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.